CDK4/6 inhibitors

CDK4/6 inhibitors are a class of medications used primarily to treat certain types of breast cancer. They work by blocking specific proteins (CDK4 and CDK6) that help cancer cells grow and divide. By inhibiting these proteins, the drugs slow down or stop cancer cell growth, making them effective in combination with hormone therapies. This approach allows for better management of the disease, improving survival rates and quality of life for patients. Commonly used CDK4/6 inhibitors include palbociclib, ribociclib, and abemaciclib.